Kwabena Siaw-Acheampong

Kwabena Siaw-Acheampong

Auto-generated profile, based on publicly available information

Kwabena Siaw-Acheampong

Department of Upper GI Surgery, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust , Birmingham

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2020 in BJS Open
Verified
Journal Article
Open access
PDF file
KSK. Siaw‐Acheampong
K. Siaw‐Acheampong
SKSivesh Kamarajah
Sivesh Kamarajah
RGR. Gujjuri
R. Gujjuri
JBJ. R. Bundred
J. R. Bundred
PSP. Singh
P. Singh
EGEwen Griffiths
Ewen Griffiths
Background: Oesophagectomy is a demanding operation that can be performed by different approaches including open surgery or a combination of minimal access techniques. This systematic review and network meta-analysis aimed to evaluate the clinical outcomes of open, minimally invasive and robotic oesophagectomy techniques for oesophageal cancer.Methods: A systematic literature search was conducted for studies reporting open oesophagectomy, laparoscopically assisted oesophagectomy (LAO), thoracoscopically assisted oesophagectomy (TAO), totally minimally invasive oesophagectomy (MIO) or robotic MIO (RAMIO) for oesophagectomy. A network meta-analysis of intraoperative (operating time, blood loss), postoperative (overall complications, anastomotic leaks, chyle leak, duration of hospital stay) and oncological (R0 resection, lymphadenectomy) outcomes, and survival was performed.Results: Ninety-eight studies involving 32 315 patients were included in the network meta-analysis (open 17 824, 55·2 per cent; LAO 1576, 4·9 per cent; TAO 2421 7·5 per cent; MIO 9558, 29·6 per cent; RAMIO 917, 2·8 per cent). Compared with open oesophagectomy, both MIO and RAMIO were associated with less blood loss, significantly lower rates of pulmonary complications, shorter duration of stay and higher lymph node yield. There were no significant differences between surgical techniques in surgical-site infections, chyle leak, and 30- and 90-day mortality. MIO and RAMIO had better 1- and 5-year survival rates respectively compared with open surgery.Conclusion: Minimally invasive and robotic techniques for oesophagectomy are associated with reduced perioperative morbidity and duration of hospital stay, with no compromise of oncological outcomes but no improvement in perioperative mortality.

22 July 2019 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
OCOesophago‐Gastric Anastomosis Study Group on behalf of the West Midlands Research Collaborative
Oesophago‐Gastric Anastomosis Study Group on behalf of the West Midlands Research Collaborative
JBJames R. Bundred
James R. Bundred
SKSivesh Kamarajah
Sivesh Kamarajah
KSKobby Siaw‐Acheampong
Kobby Siaw‐Acheampong
DNDmitri Nepogodiev
Dmitri Nepogodiev
MZMauricio Zuluaga
Mauricio Zuluaga

27 November 2024 in British Journal of Surgery
Verified
Journal Article
Closed access
BBBen E Byrne
Ben E Byrne
KSKwabena Siaw-Acheampong
Kwabena Siaw-Acheampong
OEOrla Evans
Orla Evans
JTJoanna Taylor
Joanna Taylor
FHFiona Huddy
Fiona Huddy
JWJ Whiting
J Whiting
Background: Oesophago-gastric cancer surgery negatively affects quality of life with a high postoperative symptom burden. Several conditions that may be diagnosed and treated after surgery are recognised. However, consensus regarding their definition and management is lacking. This study aimed to develop consensus regarding the definition, investigation and management of the common symptoms and conditions, and triggers to consider disease recurrence, as a foundation for improving management and quality of life in these patients. Method: Modified two-round Delphi consensus study of a multidisciplinary expert panel. Results: Eighty-six of 127 (67.7%) and 77 of 93 (82.8%) responses were received in rounds 1 and 2. Consensus was achieved in defining 26 symptoms. For 10 conditions (anastomotic stricture, acid reflux, non-acid reflux, biliary gastritis, delayed gastric emptying, dumping syndrome, exocrine pancreatic insufficiency, bile acid diarrhoea, small intestinal bacterial overgrowth and carbohydrate malabsorption), definitions, diagnostic criteria, first- and second-line investigation and first-line treatments were agreed. Consensus was not reached for third-line investigation of some conditions, or for second-, third- or fourth-line treatments for others. Twelve of 14 (85.7%) symptoms were agreed as triggers to consider cancer recurrence, during the early (1 year) postoperative periods. Conclusion: Expert consensus regarding symptoms, conditions and triggers to consider investigation for recurrence after oesophago-gastric cancer surgery was achieved. This may allow standardization and timely diagnosis and treatment of postoperative conditions, reducing variation in care and optimizing patients’ quality of life.

19 March 2019 in Diseases of the Esophagus
Verified
Journal Article
Closed access
PDF file
RER P T Evans
R P T Evans
PSP Singh
P Singh
DND Nepogodiev
D Nepogodiev
JBJ Bundred
J Bundred
SKSivesh Kamarajah
Sivesh Kamarajah
EGEwen Griffiths
Ewen Griffiths
Esophagectomy is a mainstay in curative treatment for esophageal cancer; however, the reported techniques and outcomes can vary greatly. Thirty-day mortality of patients with an intact anastomosis is 2–3% as compared to 17–35% in patients who have an anastomotic leak. The subsequent management of leaks postesophagectomy has great global variability with little consensus on a gold standard of practice. The aim of this multicentre prospective audit is to analyze current techniques of esophagogastric anastomosis to determine the effect on the anastomotic leak rate. Leak rates and leak management will be assessed to determine their impact on patient outcomes. A 12-month international multicentre prospective audit started in April 2018 and is coordinated by a team from the West Midlands Research Collaborative. This will include patients undergoing esophagectomy over 9 months and encompassing a 90-day follow-up period. A pilot data collection period occurred at four UK centers in 2017 to trial the data collection form. The audit standards will include anastomotic leak and the conduit necrosis rate should be less than 13% and major postoperative morbidity (Clavien–Dindo Grade III or more) should be less than 35%. The 30-day mortality rate should be less than 5% and the 90-day mortality rate should be less than 8%. This will be a trainee-led international audit of esophagectomy practice. Key support will be given by consultant colleagues and anesthetists. Individualized unit data will be distributed to the respective contributing sites. An overall anonymized report will be made available to contributing units. Results of the audit will be published in peer-reviewed journals with all collaborators fully acknowledged. The key information and results from the audit will be disseminated at relevant scientific meetings.